Moreover, the death receptor pathway, with caspase 8 as key regulator, was shown to be de-regulated in malignant tumor cells, such as in breast cancer cells [33, 34], in dysplastic cells or in carcinomas in situ [35]. Here, CASP8 is linked to breast cancer.